ZEN003694
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for ZEN003694, covering 2017-11-20 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers [Phase 1]